Gene · 3078
Papers1,634
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 1,634
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Lupus Nephritis Biomarkers: A Critical Review. | Int J Mol Sci | 2024 | 38255879 | PubTator, text mining | PubMed |
| The spectrum of thrombotic microangiopathy related to monoclonal gammopathy. | Clin Kidney J | 2024 | 38250251 | PubTator, text mining | PubMed |
| Levels of complement factor H-related 4 protein do not influence susceptibility to age-related macular degeneration or its course of progression. | Nat Commun | 2024 | 38200010 | PubTator, text mining | PubMed |
| Disruption of LPA-LPAR1 pathway results in lung tumor growth inhibition by downregulating B7-H3 expression in fibroblasts. | Thorac Cancer | 2024 | 38124403 | PubTator, text mining | PubMed |
| Engineered mesenchymal stem cell-derived small extracellular vesicles for diabetic retinopathy therapy through HIF-1α/EZH2/PGC-1α pathway. | Bioact Mater | 2024 | 38076648 | PubTator, text mining | PubMed |
| Protein-centric omics analysis reveals circulating complements linked to non-viral liver diseases as potential therapeutic targets. | Clin Mol Hepatol | 2024 | 38061333 | PubTator, text mining | PubMed |
| Complete biodegradation of fungicide carboxin and its metabolite aniline by Delftia sp. HFL-1. | Sci Total Environ | 2024 | 38030002 | PubTator, text mining | PubMed |
| Complement dysregulation associated with a genetic variant in factor H-related protein 5 in atypical hemolytic uremic syndrome. | Pediatr Nephrol | 2024 | 37955705 | PubTator, text mining | PubMed |
| Complement alternative pathway determines disease susceptibility and severity in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis. | Kidney Int | 2024 | 37923132 | PubTator, text mining | PubMed |
| Ksp1 is an autophagic receptor protein for the Snx4-assisted autophagy of Ssn2/Med13. | Autophagy | 2024 | 37733395 | PubTator, text mining | PubMed |
| Novel autoantibody targets identified in patients with autoimmune hepatitis (AIH) by PhIP-Seq reveals pathogenic insights. | medRxiv | 2024 | 37398174 | PubTator, text mining | PubMed |
| Rational use of eculizumab in secondary atypical hemolytic uremic syndrome. | Front Immunol | 2023 | 38274833 | PubTator, text mining | PubMed |
| The Role of the Complement System in the Pathogenesis of Infectious Forms of Hemolytic Uremic Syndrome. | Biomolecules | 2023 | 38254639 | PubTator, text mining | PubMed |
| Microbial evasion of the complement system: a continuous and evolving story. | Front Immunol | 2023 | 38239357 | PubTator, text mining | PubMed |
| Atg8 family proteins, LIR/AIM motifs and other interaction modes. | Autophagy Rep | 2023 | 38214012 | PubTator, text mining | PubMed |
| C3 Glomerulonephritis Presenting With Nephritic and Nephrotic Syndromes: Spontaneous Remission After Six Months on Dialysis. | Cureus | 2023 | 38213351 | PubTator, text mining | PubMed |
| An Update on the Genetics of IgA Nephropathy. | J Clin Med | 2023 | 38202130 | PubTator, text mining | PubMed |
| Sialic Acid Mimetic Microglial Sialic Acid-Binding Immunoglobulin-like Lectin Agonism: Potential to Restore Retinal Homeostasis and Regain Visual Function in Age-Related Macular Degeneration. | Pharmaceuticals (Basel) | 2023 | 38139861 | PubTator, text mining | PubMed |
| Longitudinal multi-omics study reveals common etiology underlying association between plasma proteome and BMI trajectories in adolescent and young adult twins. | BMC Med | 2023 | 38129841 | PubTator, text mining | PubMed |
| Proteomic analysis of glomeruli, tubules and renal interstitium in idiopathic membranous nephropathy (IMN): A statistically observational study. | Medicine (Baltimore) | 2023 | 38115247 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3078/papers?page=5